Share chart NeuroBo Pharmaceuticals, Inc.
Extended chart
Simple chart
About NeuroBo Pharmaceuticals, Inc.
NeuroBo Pharmaceuticals, Inc., биотехнологическая компания клинической стадии, которая разрабатывает и коммерциализирует мультимодальные методы лечения вирусных, невропатических и нейродегенеративных заболеваний. more details| IPO date | 2016-08-05 |
|---|---|
| ISIN | US64132R1077 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Див.доход ао | 0 |
| Сайт | https://www.neurobopharma.com |
| Цена ао | 1.89 |
| Change price per day: | 0% (1.89) |
|---|---|
| Change price per week: | 0% (1.89) |
| Change price per month: | 0% (1.89) |
| Change price per 3 month: | -8.25% (2.06) |
| Change price per half year: | -25.59% (2.54) |
| Change price per year: | -47.65% (3.61) |
| Change price per 3 year: | -92.92% (26.682) |
| Change price per 5 year: | -78.05% (8.61) |
| Change price per year to date: | -15.95% (2.2486) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| Hudson Bay Capital Management LP | 41666 | 0.85 |
| Geode Capital Management, LLC | 17332 | 0.35 |
| Blackrock Inc. | 5274 | 0.11 |
| Tower Research Capital LLC (TRC) | 2159 | 0.04 |
| Wells Fargo & Company | 25 | 0 |
| Morgan Stanley | 25 | 0 |
| Comerica Bank | 2 | 0 |
| Bank of America Corporation | 1 | 0 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Mr. Hyung-Heon Kim | CEO, President & Director | 54.22k | 1975 (50 years) |
| Mr. Marshall H. Woodworth | Chief Financial Officer | N/A | 1958 (67 years) |
| Dr. Mi-Kyung Kim | Chief Scientific Officer | N/A | |
| Mr. Robert Homolka | Senior Vice President of Clinical Operations | N/A |
Address: United States, Boston. MA, 200 Berkeley Street - open in Google maps, open in Yandex maps
Website: https://www.neurobopharma.com
Website: https://www.neurobopharma.com
